Supplement to G20AI67347 to complete critical upgrades to the Rutgers RBL
Supplement to G20AI67347 to complete critical upgrades to the Rutgers RBL
批准号:
10631469
负责人:
David Alland
金额:
$191.33万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-22 至 2024-02-29
关键词:
AerosolsAnimal ExperimentsAutopsyBiochemistryCOVID-19ClinicClinicalComputer SecurityCustomDental SchoolsEquipmentFacultyFeesFloorFundingGrantHousingIndividualInstitutesIntentionLaboratoriesLocationMicrobiologyMolecular GeneticsNew JerseyOryctolagus cuniculusParentsProceduresPublic HealthResearchResearch InstituteResearch PersonnelResourcesRodentRunningScientistTechnologyTrainingTuberculosisUnited States National Institutes of HealthUniversitiesUniversity HospitalsWalkingWorkanimal carebiosafety level 3 facilitycostdesignexperimental studyinternational centermedical schoolsmemberpathogenpublic health researchtissue culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Overview of the RBL. The Rutgers RBL is located at 225 Warren Street in Newark, New Jersey. This location
is within a few blocks of the New Jersey Institute of Technology (NJIT) and the Rutgers – Newark main campuses
and a seven-minute walk from the Rutgers – New Jersey Medical and Dental School’s campus and the adjoining
University Hospital. The RBL is physically attached to the International Center for Public Health (ICPH) building.
The RBL provides > 50% of the BSL3 laboratory and BSL3 vivarium (ABSL3) space to the Rutgers campuses.
This capacity is augmented by the ICPH building, which also contains additional BSL3 and ABSL3 space that is
run along with the RBL as a single facility by the RBL Director, Dr. David Alland. The ICPH houses the Public
Health Research Institute, the Rutgers – New Jersey Medical School Department of Microbiology, Biochemistry
and Molecular Genetics, and the International Center for Tuberculosis Excellence. A Tuberculosis Clinic is
situated in clinical space on the ICPH first floor. Together the facilities and activities in the ICPH building support
and augment research performed in the RBL, and investigators performing high threat pathogen research make
use of the resources available in the RBL.
The first floor of the RBL is fully dedicated as an ABSL3 facility, which includes 6 procedure/housing suites
for rodents and rabbits including housing rooms, custom-designed biosafety enclosures, tissue culture labs,
procedure rooms, dedicated rooms for aerosol challenge, and a necropsy room. Animal care is supported by per
diem fees, while most of the animal experiments are performed by scientists who are certified to work in the
facility and supported by individual NIH grants. A new COVID-19 core within the ABSL3 includes BSL3 trained
staff who can perform COVID-19 related experiments requiring BSL3 facilities for scientists who are not able to
work in the BSL3 by themselves. This core is mostly supported by Rutgers University funds, with the intention to
transition this core to eventually be self-sustaining financially. The second floor of the RBL is split equally
between BSL3 Lab space and Biosafety Level 2 (BSL2) resident labs and support space, which are headed by
several faculty members. The new COVID-19 BSL3 core also uses the facilities on the second floor RBL for
COVID-19 core studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resources, Workforce Development, and Animal Models for the Rutgers RBL
-
批准号:10793863
-
项目类别:
-
资助金额:$397.07万
-
财政年份:2023
-
负责人:David Alland
-
依托单位:
Key Facility Upgrades for the Rutgers University RBL.
-
批准号:10393791
-
项目类别:
-
资助金额:$332.84万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
批准号:10493254
-
项目类别:
-
资助金额:$265.83万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
批准号:10665016
-
项目类别:
-
资助金额:$265.83万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
批准号:10271644
-
项目类别:
-
资助金额:$275.15万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
-
批准号:10907954
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Administrative Core
-
批准号:10493259
-
项目类别:
-
资助金额:$13.8万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Administrative Core
-
批准号:10271645
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
Administrative Core
-
批准号:10665018
-
项目类别:
-
资助金额:$13.52万
-
财政年份:2021
-
负责人:David Alland
-
依托单位:
FEND for TB
-
批准号:10180898
-
项目类别:
-
资助金额:$395.47万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosis
-
批准号:10584487
-
项目类别:
-
资助金额:$81.26万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Novel and Optimized Diagnostics for Pediatric TB
-
批准号:10673360
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Bacteria and Host in TB Transmission
-
批准号:10390418
-
项目类别:
-
资助金额:$181.62万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Novel and Optimized Diagnostics for Pediatric TB
-
批准号:10905419
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Bacteria and Host in TB Transmission
-
批准号:10598015
-
项目类别:
-
资助金额:$169.71万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Simple and rapid POC detection for fungemia
-
批准号:10542776
-
项目类别:
-
资助金额:$76.47万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
FEND for TB
-
批准号:10409690
-
项目类别:
-
资助金额:$416.72万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
FEND for TB
-
批准号:9981978
-
项目类别:
-
资助金额:$399.8万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
FEND for TB
-
批准号:10654567
-
项目类别:
-
资助金额:$394.33万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
Novel and Optimized Diagnostics for Pediatric TB
-
批准号:10615049
-
项目类别:
-
资助金额:$108.88万
-
财政年份:2020
-
负责人:David Alland
-
依托单位:
海外基金